Share on StockTwits

Shares of Tenet Healthcare Corp (NYSE:THC) have earned an average recommendation of “Hold” from the nineteen brokerages that are covering the company, AR Network reports. Ten investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $63.46.

In other Tenet Healthcare Corp news, Insider Britt T. Reynolds sold 8,028 shares of Tenet Healthcare Corp stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $58.49, for a total transaction of $469,557.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Tenet Healthcare Corp (NYSE:THC) traded up 0.22% during mid-day trading on Tuesday, hitting $60.3002. The stock had a trading volume of 218,152 shares. Tenet Healthcare Corp has a one year low of $36.87 and a one year high of $60.24. The stock’s 50-day moving average is $51.24 and its 200-day moving average is $46.17. The company’s market cap is $5.904 billion.

Tenet Healthcare Corp (NYSE:THC) last posted its quarterly earnings results on Monday, August 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.28. The company had revenue of $4.04 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the company posted $0.66 earnings per share. The company’s quarterly revenue was up 66.9% on a year-over-year basis. On average, analysts predict that Tenet Healthcare Corp will post $1.39 earnings per share for the current fiscal year.

A number of research firms have recently commented on THC. Analysts at RBC Capital raised their price target on shares of Tenet Healthcare Corp from $43.00 to $62.00 in a research note on Thursday, August 14th. They now have a “sector perform” rating on the stock. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Tenet Healthcare Corp in a research note on Wednesday, August 6th. They now have a $66.00 price target on the stock, up previously from $52.00. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Tenet Healthcare Corp in a research note on Wednesday, August 6th. They now have a $63.00 price target on the stock, up previously from $51.00.

Tenet Healthcare Corporation (NYSE:THC) along with its subsidiaries, is an investor-owned health care services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.